Current directions in radiopharmaceutical research and development
著者
書誌事項
Current directions in radiopharmaceutical research and development
(Developments in nuclear medicine, v. 30)
Kluwer Academic Publishers, c1996
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.
目次
- Foreword
- K.E. Britton. Preface. 1. Radiopharmaceutically Relevant Chemistry of Technetium and Rhenium
- J.R. Dilworth, S.J. Parrott. 2. Bifunctional Chelators for Technetium-99m
- A.M. Verbruggen. 3. Medium Half-Life Inorganic Radionuclides for PET Imaging
- J. Zweit. 4. Therapeutic Radionuclides: Making the Right Choice
- S.C. Srivastava. 5. Radiopharmaceuticals for Imaging Hypoxia
- C.M. Archer, et al. 6. Genetic Engineering of Monoclonal Antibodies
- L.M.D. Stewart. 7. The Development of Radiopharmaceuticals for Imaging CNS Receptors
- H.F. Kung. 8. Imaging the Functions of the Cell Nucleus
- L.I. Wiebe. 9. Steroid Hormone Receptors as Targets for Diagnostic Imaging
- M.J. Welch, et al. 10. Radiolabelling Oligonucleotides with Imageable Radionuclides
- D.J. Hnatowich. 11. Radioligand Binding Assays: Theory and Practice
- A.P. Davenport, F.D. Russell. 12. Molecular Modelling - An Introduction
- D. Barlow. 13. Computer Modelling of Metal-Based Radiopharmaceuticals
- R.D. Hancock. 14. Microautoradiography
- P.J. Blower. Index.
「Nielsen BookData」 より